☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update - June 2009

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for June 2009 (PDF).

This issue contains stop press information about a potential interaction between clopidogrel and proton pump inhibitors, counterfeit NovoFine® needles and hepatitis risk from incorrect use of lancet devices. Drug safety advice covers the following areas:

  • Antipsychotics: risk of venous thromboembolic events
  • Chloral hydrate and Triclofos: not first-line options for insomnia
  • Oral salicylate gels: not for use in those younger than age 16 years
  • Topical ketoprofen: reminder on risk of photosensitivity reactions

Action: Clinicians will find this publication to be a useful review of current issues in drug safety.

Share 'Drug Safety Update - June 2009' by emailShare 'Drug Safety Update - June 2009' on FacebookShare 'Drug Safety Update - June 2009' on TwitterShare 'Drug Safety Update - June 2009' on LinkedInShare 'Drug Safety Update - June 2009' on reddit


No Comments to “Drug Safety Update - June 2009”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.